Literature DB >> 18754320

Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus.

Tamara Vorobjova1, Heidi-Ingrid Maaroos, Raivo Uibo.   

Abstract

The aim of the study was to establish possible factors which play a role in progression of gastritis to atrophic gastritis in long-term follow-up among the Estonian population, to assess the association between the host immune response and different Helicobacter pylori antigens and autoantigens in relation to the histological parameters of gastritis in the antrum and corpus. ELISA and immunoblot were used for detection of IgG to H. pylori acid glycine-extracted cell surface proteins, CagA protein, and H. pylori HSP60. Anticanalicular autoantibodies (ACAB) in the serum were evaluated according to Faller et al. (1996). Apoptosis was evaluated using the TUNEL method. Study subjects were 1958 persons from an unselected Estonian population, and 70 persons from a sample from Saaremaa Island, who had been investigated over a period of 18 years. Seropositivity for CagA was a sign of gastritis activity [OR=14.8 (4.5-50.3)] and atrophy [OR=7.0 (2.1-23.1)] and might predict development of atrophy, particularly in the corpus [OR=7.1 (1.8-27.7)]. The prevalence of ACAB increased significantly with duration of H. pylori gastritis from 22% in 1985 to 46% in 1997 (p=0.004). Immune response to H. pylori HSP60 indicates chronic inflammation in the antrum (p=0.003). Apoptosis of gastric epithelial cells is largely dependent on grade of activity of gastritis, and, particularly in the antrum, on grade of H. pylori colonization (p=0.01; p=0.02), but is not associated with development of atrophy. Seropositivity for different H. pylori antigens (CagA, HSP 60) serves as a marker of different histological manifestations in the antrum and corpus mucosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754320     DOI: 10.1111/j.1600-0463.2008.00934.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?

Authors:  Banu Kara; Hikmet Akkiz; Figen Doran; Suleyman Bayram; Eren Erken; Yuksel Gumurdullu; Macit Sandikci
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

Review 2.  Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies.

Authors:  Mariam Abdullahi Adamu; Melanie Nicole Weck; Lei Gao; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2010-06-29       Impact factor: 8.082

3.  Helicobacter pylori Omp18 and its application in serologic screening of infection.

Authors:  Yeganeh Talebkhan; Fatemeh Ebrahimzadeh; Maryam Esmaeili; Leili Zamaninia; Azin Nahvijoo; Hossein Khedmat; Forouzandeh Fereidooni; Mohammad Ali Mohagheghi; Marjan Mohammadi
Journal:  Curr Microbiol       Date:  2010-07-23       Impact factor: 2.188

4.  Predictive value of neutrophil infiltration as a marker of Helicobacter pylori infection.

Authors:  Xiao-Qing Xu; Zhen-Hua Wang; Jing-Xian Liao; Xiao-Yu Chen; Wen-Zhong Liu; Shu-Dong Xiao; Hong Lu
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

5.  Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional study.

Authors:  Tajana Filipec Kanizaj; Miroslava Katicić; Vladimir Presecki; Slavko Gasparov; Vesna Colić Cvrlje; Branko Kolarić; Anna Mrzljak
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

Review 6.  The differential diagnosis of Helicobacter pylori negative gastritis.

Authors:  Hala El-Zimaity; Won-Tak Choi; Gregory Y Lauwers; Robert Riddell
Journal:  Virchows Arch       Date:  2018-09-25       Impact factor: 4.064

Review 7.  Chronic gastritis.

Authors:  Pentti Sipponen; Heidi-Ingrid Maaroos
Journal:  Scand J Gastroenterol       Date:  2015-04-22       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.